6505--Ibuprofen Tablets

The Department of Veterans Affairs National Acquisition Center is seeking a pharmaceutical prime vendor to supply Ibuprofen tablets in multiple strengths and package configurations. The procurement covers six line items of Ibuprofen tablets in 400mg, 600mg, and 800mg strengths, packaged in bottles of 100 and 500 tablets each, to serve the VA, Indian Health Service, Bureau of Prisons, and Captain James A. Lovell Federal Health Care Center. Offerors must provide a unique 11-digit National Drug Code for each product offered and include a 0.5% Cost Recovery Fee in their pricing structure. The solicitation requires submission of pricing for a base year plus four one-year option periods, along with a Letter of Commitment from the manufacturer. The proposal deadline has been extended from the original June 17, 2025 date to July 29, 2025 at 2:30 PM Central Daylight Time, and proposals will be evaluated using a lowest-price technically acceptable methodology.

This procurement is designated as a small business set-aside with a size standard of 1,300 employees under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The contract will be distributed through the VA Pharmaceutical Prime Vendor program, which is currently operated by McKesson Corporation as the incumbent contractor. The total estimated annual usage varies significantly across line items, ranging from 4,347 bottles for certain configurations up to 149,880 bottles for others, indicating substantial volume requirements. The solicitation covers procurement for multiple federal healthcare facilities and agencies, demonstrating the broad scope of the government's pharmaceutical distribution needs. All proposals must be submitted electronically, and the contract structure includes multiple option years to provide continuity of pharmaceutical supply services.